APCER Life Sciences

APCER Life Sciences is committed to improving health in partnership with its clients as we bring together safety, medical, regulatory, and technology resources.

[APCER Life Sciences @apcerls]

Why is the role of a PV contact person or QPPV so crucial in drug safety? Our blog dives into how they lead pharmacovigilance activities, handle global regulatory demands, and ensure compliance. Don't miss out! Click here to learn more: https://t.co/OkHDxed62e

#pharmacovigilance

[APCER Life Sciences @apcerls]

Reviewers and writers on our CMC team delivered high quality chemical and product development reports on time. To learn more, click here: https://t.co/P4NejparA5

#cmc #cmcwriting #ndafiling #fdaapproval #fda #regulatorycompliance #regulatory #regulatoryaffairs #drugsafety

[APCER Life Sciences @apcerls]

APCER's strategic planning and rapid execution ensured a flawless transition for a global biologics leader's post-marketing case intake through proactive hiring, swift resource mobilization, and effective client engagement. https://t.co/FxgU0NOL1Z

#casestudy #pharmacovigilance

[APCER Life Sciences @apcerls]

We helped a Large Pharma establish an Integrated PV system across locations, globally. Download the case study to learn more: https://t.co/FgAjUxknTf

#pharmacovigilance #drugsafety #pharmaceutical #regulatory #signaldetection

[APCER Life Sciences @apcerls]

Click here to know more about the key changes in post-marketing requirements for medical devices under the EU Medical Device Regulation: https://t.co/A4U98H9VaI

#adverseevents #global #medicaldevice #medicaldevices #patientsafety #eumdr #postmarketsurveillance

[APCER Life Sciences @apcerls]

Importance of a robust PV system combined with internal capability and outsourced expertise early enough ensures that any safety risk arising out of the clinical development program for ATMPs/CGTS can be managed in time. Know more from our latest blog! https://t.co/ZszhlgB5h2

[APCER Life Sciences @apcerls]

Discover the key components, requirements, and solutions to key risks in Risk Evaluation and Mitigation Strategy (REMS) - and how you can effectively manage them. Check out our latest article! https://t.co/kZs4QMC5Zx

#riskmanagment #riskmitigation #riskminimisationmeasure #rems

[APCER Life Sciences @apcerls]

We enabled a global Life Sciences company file for earlier approval by handling complex and large volumes of e-submission-ready documents in a short duration of time. Click here to read more: https://t.co/7sK8GycQoK

#medicalwriting #regulatorycompliance #medicalwriters

[APCER Life Sciences @apcerls]

Health care professionals (HCPs) and patients should be informed immediately of any safety concerns or risks related to the use of your medicine. See our latest white paper for more information about the effective implementation of PSUSA recommendations: https://t.co/5qkvLTKNta

[APCER Life Sciences @apcerls]

Accurate and timely responses to inspectors is critical during a regulatory inspection. Read more about how our responsive teams worked closely with site personnel to host a successful regulatory inspection. https://t.co/BpDr0yKAnK

#pharmacovigilance #drugsafety #pharmaceutical

[APCER Life Sciences @apcerls]

The terms RLD, reference standard and basis of submission have created confusion amongst stakeholders. Learn about making an effective ANDA application in our latest blog: https://t.co/UXYkVBXHE9

#anda #rld #newdrugapplication #nda #bioequivalence #usfda #referencestandard

[APCER Life Sciences @apcerls]

The chemical and product development reports developed by our team of CMC writers resulted in a high-quality CMC section of the NDA. You can download the case study here: https://t.co/P4Nejp9TKx

#cmc #cmcwriting #ndafiling #fdaapproval #fda #regulatorycompliance #regulatory

[APCER Life Sciences @apcerls]

Early onboarding of a specialized pharmacovigilance partner can help manage the drug safety profile of your product throughout the drug lifecycle. Click here to learn more: https://t.co/bgq6hK73MW

#pharmacovigilance #drugsafety #organizationalagility #scientific #domainexpertise

[APCER Life Sciences @apcerls]

Partnering with a specialised safety provider can help companies set-up cost-effective and agile PV operations in a time bound manner. View our case study on how we helped a US biopharma company setup an efficient PV system: https://t.co/pAXSIh1L5Z

#pharmacovigilance #drugsafety

[APCER Life Sciences @apcerls]

Find out about the EU regulatory framework for PSUSA procedures, their assessment, and the timeframes for submitting variations for implementing the outcome of a PSUSA procedure in our whitepaper: https://t.co/5qkvLTKNta

#drugsafety #PSUSA #drugdevelopment #patientcare

[APCER Life Sciences @apcerls]

We are delighted to announce our association with REMS Industry Consortium (RIC) as a Silver Industry Partner, leading the way in patient-centric pharmacovigilance solutions globally!

#pharmacovigilance #riskmanagement #rems #medicalinformation #regulatoryaffairs #ric

[APCER Life Sciences @apcerls]

Learn how our strong scientific evidence backed by scientific data helped one of our clients to engage with key opinion leaders and physicians to reposition one of their medicinal product effectively in the market. Download our case study now: https://t.co/oi8g43yWDx

[APCER Life Sciences @apcerls]

How partnering with a firm that specializes in regulatory, safety, and compliance can ensure Medical Device companies comply with the guidelines laid out by regulatory agencies? Learn more here: https://t.co/A4U98H9nla

#adverseevents #global #medicaldevice #medicaldevices

[APCER Life Sciences @apcerls]

Find out how REMS addresses critical safety concerns of certain medicinal products to make sure that the benefits of medicine exceed the risks. https://t.co/kZs4QMC5Zx

#riskmanagment #riskmitigation #riskminimisationmeasure #rems #fda #riskbenefit #pharmacovigilance

[APCER Life Sciences @apcerls]

Reviewers and writers on our CMC team delivered high quality chemical and product development reports on time. To learn more, click here: https://t.co/P4Nejp9TKx

#cmc #cmcwriting #ndafiling #fdaapproval #fda #regulatorycompliance #regulatory #regulatoryaffairs #drugsafety